National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

becatecarin
A synthetic diethylaminoethyl analogue of the indolocarbazole glycoside antineoplastic antibiotic rebeccamycin. Becatecarin intercalates into DNA and stabilizes the DNA-topoisomerase I complex, thereby interfering with the topoisomerase I-catalyzed DNA breakage-reunion reaction and initiating DNA cleavage and apoptosis. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonyms:DEAE-rebeccamycin
rebeccamycin analogue
rebeccamycin analogue, tartrate salt
Code names:BMS-181176
BMY-27557-14
XL119
Chemical structure name:5H-indolo(2,3-a)pyrrolo(3,4-c)carbazole-5,7(6H)-dione, 1,11-dichloro-6-(2-(diethylamino)ethyl)-12,13-dihydro-12-(4-O-methyl-beta-D-glucopyranosyl)-



Previous:bcr-abl (b3a2)-derived peptide vaccine, bcr-abl p210-b3a2 breakpoint-derived multipeptide vaccine, bcr-abl peptide vaccine, BEACOPP regimen, Bead Block Compressible Microspheres
Next:Becenum, beclomethasone dipropionate, Beclovent, Beconase, Beesix

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov